Esperion Therapeutics
Esperion Therapeutics, Inc. (Nasdaq: ESPR) is a commercial-stage pharmaceutical company based in Ann Arbor, Michigan, focused on discovering, developing, and commercializing innovative medicines that lower LDL cholesterol and reduce cardiovascular risk. Its lead products are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe), oral, once-daily, non-statin therapies indicated to lower elevated LDL-C in adults. As a life-sciences company, Esperion operates a corporate and scientific marketing web presence rather than a developer program; it publishes no public API, developer portal, SDKs, or technical documentation. This profile was added to the API Evangelist network as a venture-portfolio lead and enriched with verifiable company identity and domain-security signals only.
Esperion Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Pharmaceutical, Biotechnology, Life Sciences, and Cardiovascular.
Esperion Therapeutics’ developer surface includes support and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API